Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Retrospective Clinical Results of the Combined Use of Immunoglobulin and Pulse Steroid Therapies in Severe Covid-19 Patients Followed in Intensive Care Unit

NCT06223984 is registered in ClinicalTrials.gov with Konya City Hospital as lead sponsor.

NCT NCT06223984
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06223984 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Retrospective Clinical Results of the Combined Use of Immunoglobulin and Pulse Steroid Therapies in Severe Covid-19 Patients Followed in Intensive Care Unit
Lead sponsor
Konya City Hospital
Phase
Phase 4
Overall status
Completed
Start date
March 30, 2020
Completion date
November 14, 2020
Enrollment
178 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pulse steroid and immunoglobulins drugs in covid 19 patients